UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 15

OMB APPROVAL
  OMB Number: 3235-0167
Expires: March 31, 2021
Estimated average burden
hours per response.... 1.50
   
   

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

 

Commission File Number: 002-41703

 

OMNICANNA HEALTH SOLUTIONS, INC.

(Exact name of registrant as specified in its charter)

 

2910 North Powers Boulevard, Suite 125

Colorado Springs, Colorado 80922

Telephone: 1-866-326-5595

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

 

Common Stock, $0.001 par value

(Title of each class of securities covered by this Form)

 

None

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

 

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 

Rule 12g-4(a)(1)        ☒

Rule 12g-4(a)(2)       ☐

Rule 12h-3(b)(1)(i)    ☐

Rule 12h-3(b)(1)(ii)   ☐

Rule 15d-6                ☐

Rule 15d-22(b)         ☐

 

Approximate number of holders of record as of the certification or notice date: 77

 

Pursuant to the requirements of the Securities Exchange Act of 1934 Omnicanna Health Solutions, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

 

Date:  December 10, 2019 By: /s/ Robert Kane
    Robert Kane
  Title:  Chief Operating Officer & Director

 

 

 

 

 

 

Endocan (CE) (USOTC:ENDO)
Historical Stock Chart
Von Dez 2024 bis Jan 2025 Click Here for more Endocan (CE) Charts.
Endocan (CE) (USOTC:ENDO)
Historical Stock Chart
Von Jan 2024 bis Jan 2025 Click Here for more Endocan (CE) Charts.